SILO PHARMA, INC. Accounts Payable, Other, Current
SILO PHARMA, INC. (SILO) had Accounts Payable, Other, Current of $35.92 thousand as of 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Notes › Payables and Accruals › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableOtherCurrent · last filed 2024-08-13
- 2024-06-30: Accounts Payable, Other, Current $35.92K.
- 2024-03-31: Accounts Payable, Other, Current $0.00.
- 2023-12-31: Accounts Payable, Other, Current $0.00.
| Period end | Accounts Payable, Other, Current |
|---|---|
| 2024-06-30 | $35.92K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-13 |
| 2023-12-31 | $0.00 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |